Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 376

Results For "UST"

3928 News Found

ACG Films & Foils partners Danapak Flexibles A/S for the Indian market
Packaging | August 05, 2021

ACG Films & Foils partners Danapak Flexibles A/S for the Indian market

Innovative solutions and a deep understanding of the market makes this a unique combination


Clarivate  acquires Bioinfogate
Digitisation | August 05, 2021

Clarivate acquires Bioinfogate

Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences


Dr Reddy’s relaunch Naproxen Sodium Tablets in the US
News | August 04, 2021

Dr Reddy’s relaunch Naproxen Sodium Tablets in the US

It is part of the company’s pain/analgesics portfolio of OTC products


NATCO Pharma transfers Lenalidomide ANDA to Arrow
News | August 04, 2021

NATCO Pharma transfers Lenalidomide ANDA to Arrow

Arrow is the marketing partner in US


Aartas launches co-working space for doctors under Clinishare
Healthcare | August 04, 2021

Aartas launches co-working space for doctors under Clinishare

Startup receives US $ 5 million in first round of funding


India Initiates anti dumping probe against import of ATS-8 from China
Policy | August 04, 2021

India Initiates anti dumping probe against import of ATS-8 from China

Arch Pharma Labs has filed the application


Wipro GE Healthcare introduces remote monitoring solution for COVID 19
Healthcare | August 04, 2021

Wipro GE Healthcare introduces remote monitoring solution for COVID 19

Apollo hospital-Hyderabad, Kainos Hospital-Rohtak and Apex Hospital Jaipur have deployed this solution


Evexia Lifecare to manufacture API of Isometa
News | August 03, 2021

Evexia Lifecare to manufacture API of Isometa

Robust demand for the product across the Middle East, Africa and Latin America


AYUSH 64 effective in mild and moderate COVID 19
Drug Approval | August 03, 2021

AYUSH 64 effective in mild and moderate COVID 19

It works as an adjunct to standard care based on robust clinical trials


Nureca Ltd PAT at Rs 36.19 crore in Q1FY22
Healthcare | August 03, 2021

Nureca Ltd PAT at Rs 36.19 crore in Q1FY22

Nureca Ltd has reported financial results for the period ended June 30, 2021.